T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation - Tập 23 - Trang 648-653 - 2017
Joan How1, Michael Slade1, Khoan Vu1, John F. DiPersio1, Peter Westervelt1, Geoffrey L. Uy1, Camille N. Abboud1, Ravi Vij1, Mark A. Schroeder1, Todd A. Fehniger1, Rizwan Romee1
1BMT and Leukemia Program, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri

Tài liệu tham khảo

Estey, 2006, Acute myeloid leukaemia, Lancet, 368, 1894, 10.1016/S0140-6736(06)69780-8

Zittoun, 1995, N Engl J Med, 332, 217, 10.1056/NEJM199501263320403

Cassileth, 1998, Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission, N Engl J Med, 339, 1649, 10.1056/NEJM199812033392301

Mrozek, 2012, Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia, J Clin Oncol, 30, 4515, 10.1200/JCO.2012.43.4738

Duval, 2010, Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure, J Clin Oncol, 28, 3730, 10.1200/JCO.2010.28.8852

Craddock, 2011, Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia, Leukemia, 25, 808, 10.1038/leu.2011.13

Michallet, 2000, Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), Bone Marrow Transplant, 26, 1157, 10.1038/sj.bmt.1702690

Biggs, 1992, Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy, Blood, 80, 1090, 10.1182/blood.V80.4.1090.1090

Bashey, 2013, T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation, J Clin Oncol, 31, 1310, 10.1200/JCO.2012.44.3523

Ciurea, 2015, Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia, Blood, 126, 1033, 10.1182/blood-2015-04-639831

Rashidi, 2016, Comparison of outcomes after peripheral blood haploidentical versus matched unrelated donor allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia: a retrospective single-center review, Biol Blood Marrow Transplant, 22, 1696, 10.1016/j.bbmt.2016.05.010

O'Donnell, 2002, Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide, Biol Blood Marrow Transplant, 8, 377, 10.1053/bbmt.2002.v8.pm12171484

Luznik, 2008, HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide, Biol Blood Marrow Transplant, 14, 641, 10.1016/j.bbmt.2008.03.005

Gragert, 2014, HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry, N Engl J Med, 371, 339, 10.1056/NEJMsa1311707

Besse, 2016, On modeling human leukocyte antigen-identical sibling match probability for allogeneic hematopoietic cell transplantation: estimating the need for an unrelated donor source, Biol Blood Marrow Transplant, 22, 410, 10.1016/j.bbmt.2015.09.012

Kasamon, 2010, Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome, Biol Blood Marrow Transplant, 16, 482, 10.1016/j.bbmt.2009.11.011

Wang, 2011, Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison, Biol Blood Marrow Transplant, 17, 821, 10.1016/j.bbmt.2010.08.023

Jaiswal, 2016, Biol Blood Marrow Transplant, 22, 1867, 10.1016/j.bbmt.2016.07.016

Ljungman, 2002, Definitions of cytomegalovirus infection and disease in transplant recipients, Clin Infect Dis, 34, 1094, 10.1086/339329

Sorror, 2005, Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT, Blood, 106, 2912, 10.1182/blood-2005-05-2004

Przepiorka, 1995, 1994 Consensus conference on acute GVHD grading, Bone Marrow Transplant, 15, 825

Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004

Araki, 2016, Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease-based definition of complete remission?, J Clin Oncol, 34, 329, 10.1200/JCO.2015.63.3826

Drobyski, 2002, Blood, 99, 806, 10.1182/blood.V99.3.806

Kanda, 2003, Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000), Blood, 102, 1541, 10.1182/blood-2003-02-0430

McCurdy, 2016, Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with posttransplantation cyclophosphamide, Haematologica

Solh, 2016, Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantation, Bone Marrow Transplant, 51, 949, 10.1038/bmt.2016.62

Zeidan, 2014, HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation, Biol Blood Marrow Transplant, 20, 314, 10.1016/j.bbmt.2013.11.020

Ghiso, 2015, DLI after haploidentical BMT with post-transplant CY, Bone Marrow Transplant, 50, 56, 10.1038/bmt.2014.217

Ji, 2002, G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia, Bone Marrow Transplant, 30, 861, 10.1038/sj.bmt.1703769

Weiden, 1981, Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation, N Engl J Med, 304, 1529, 10.1056/NEJM198106183042507

Ringden, 2009, The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation, Blood, 113, 3110, 10.1182/blood-2008-07-163212

Thông tin
Thông tin xuất bản

Biology of Blood and Marrow Transplantation

Tập 23

648-653

Thông tin tác giả